Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma.

Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34097983

about

Role of MicroRNAs-221/222 in Digestive Systems Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity Role of microRNAs in hepatocellular carcinoma: a clinical perspective Guide for diagnosis and treatment of hepatocellular carcinoma Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27 MiRNA-221 negatively regulated downstream p27Kip1 gene expression involvement in pterygium pathogenesis.A meta-analysis of the relationship between glutathione S-transferases gene polymorphism and hepatocellular carcinoma in Asian population.Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis.MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma.miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB.MiR-222 in Cardiovascular Diseases: Physiology and Pathology Role of microRNAs in inflammation-associated liver cancer Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.miR221/222 in cancer: their role in tumor progression and response to therapy.Apoptosis and microRNA aberrations in cancer.The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.The role of miRNAs in cancer: from pathogenesis to therapeutic implications.Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221.miRNA for diagnosis and clinical implications of human hepatocellular carcinoma.Mir-221/222 are promising targets for innovative anticancer therapy.Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cells.MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway.MicroRNA-221/222 regulate ox-LDL-induced endothelial apoptosis via Ets-1/p21 inhibition.MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2.miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs.MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway.Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker.[Expression of MiRNA-221 in non-small cell lung cancer tissues and correlation with prognosis].

P2860

Q26799877-87F5D119-B883-4479-AA9A-0AEE6D478E66 Q26853543-EB8BC944-031D-4D0F-8390-E423CBBFF9F7 Q27008271-2453B081-68D3-4EB9-B879-2FE0BE961175 Q27010233-57613DEC-8E87-4032-BD9A-6CF702A21DB7 Q27014034-85C53DE5-39A4-46F9-8165-0D5D4119CA36 Q28084003-1E174CE3-A75E-430C-BD3C-6491BF27462A Q28272678-6688EDBB-8204-4775-AD7A-752DCA9ACF96 Q33756226-956D0076-3A5C-42B8-90A2-4A42937C1F76 Q33926612-2E4B4617-BD35-4583-8CF7-148F805C9CCC Q34440162-46E45570-A73B-483A-84D5-99B71693BE35 Q34548464-686FE776-A312-481C-8D3D-809134CD5584 Q34621874-B724E05B-099D-4A14-872D-DEBBCA1B92B6 Q35715931-17D50358-62EE-457E-8E82-EDCA3B435658 Q36884764-014B9833-A40A-4F7D-8E7A-E8CA0FB862E9 Q37016562-5B4CD4BD-EE25-4B9D-A21A-E6659E00B6F2 Q37448131-C0CC1609-641D-4F2E-B900-95F303000545 Q37588696-AC756713-45C8-421E-8702-C006D3220016 Q37596666-9247FBBE-C6BC-4CE5-AE4B-E76770FAE986 Q37643929-D61649D6-ECF9-4A39-9D6D-523B2FA94F34 Q37955986-9EBC5889-D3AE-43AE-BFC0-164ECFD02CA4 Q37992691-8DA3B60F-8112-4C2E-A5C3-C516F1E93835 Q38178032-8B7D1FC1-1615-4B70-9EC5-5F097CC690A8 Q38221290-82A15C5A-D27C-4D94-A00F-B40A19B07BC3 Q38314583-5C8E0615-8A62-417F-8A92-67577380574D Q38568853-25570D1F-83FC-47BB-B63C-07B371FB6EA7 Q38767024-7468144C-5B92-40CA-B8FF-7E64B00C1A3E Q38772085-5CCD6385-C3F3-4C69-A060-D04A3F774789 Q38826622-0944C088-3E8B-480C-B56B-A609CBE104D3 Q38884615-CE06B07F-4BB3-41C0-A4EA-696E34BBB7B9 Q38904607-F761C200-33E5-4EAF-BDC3-A26F5F288DED Q40066973-E27B1F66-52B9-4AD5-A54D-CF2C52A7ACBC Q47696168-640FE878-39CD-4209-967C-CA4576D14E98 Q52721971-9B57EB88-C7B8-4F2A-9A94-D72557357641 Q54519450-B22908F5-0D5B-4CC3-A684-1CCB34D2E8E5 Q55273685-64430C57-54A5-4A35-AB86-FAD83E699A27 Q55512526-354DAAED-941D-4678-9878-5C77864D0445

P2860

Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34097983

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Clinical significance of miR-2 ...... ¹ in hepatocellular carcinoma.

@ast

Clinical significance of miR-2 ...... ¹ in hepatocellular carcinoma.

@en

Clinical significance of miR-2 ...... ¹ in hepatocellular carcinoma.

@nl

type

label

Clinical significance of miR-2 ...... ¹ in hepatocellular carcinoma.

@ast

Clinical significance of miR-2 ...... ¹ in hepatocellular carcinoma.

@en

Clinical significance of miR-2 ...... ¹ in hepatocellular carcinoma.

@nl

prefLabel

Clinical significance of miR-2 ...... ¹ in hepatocellular carcinoma.

@ast

Clinical significance of miR-2 ...... ¹ in hepatocellular carcinoma.

@en

Clinical significance of miR-2 ...... ¹ in hepatocellular carcinoma.

@nl

P1433

Q34097983-0BF328B7-D677-4BE5-BE79-8E2A187D6AED

P1476

Q34097983-CB1089A5-E414-4BEE-B07E-921AD20BB363

P2093

Q34097983-102F65A2-821A-4F0D-B3AF-D2EF54A7B1D6

Q34097983-24517D72-A21A-4EDF-970A-D711568B66E8

Q34097983-2CCE5592-E86D-4BC0-8259-C2FDB56EA169

Q34097983-2F113D75-DC0D-4F86-A639-61FC6EA7A02C

Q34097983-47779282-08F0-4E67-8E31-7006A6F5C66C

Q34097983-516C640F-CBCE-4676-B08D-CAF925E9CC6B

Q34097983-8CE5B3B2-32F0-4E1A-BA6B-E1E9318EFF8C

Q34097983-8E88DB8F-676C-46D9-9CEB-78510A0A6D8C

Q34097983-951F55C9-B1A5-4783-B72F-704E076B1B27

Q34097983-C0D4C83F-A89D-4E8E-AA3F-21F7AE5D9A71

P2860

Q34097983-12371841-4EBE-4129-BDB7-35018B2958CE

Q34097983-211DF224-EA31-4566-B412-60A5615ACDBA

Q34097983-2C174F3C-181C-4DBF-812E-C8116D897B0D

Q34097983-5EDBB42B-4178-4993-9339-744BD7056FE2

Q34097983-6CC27C26-B167-427E-A793-3E62D2C58E8D

Q34097983-6E205FD3-0D99-4746-A572-4C81F76A187F

Q34097983-71D9D708-77E6-4B9B-8188-5CB5B096CDDB

Q34097983-762B6A18-4FB6-4B42-9F8C-49D83A6D36FF

Q34097983-886FC7A8-A173-4886-88C4-8B3240434712

Q34097983-A80A91EA-6CAA-4A6A-B5AC-34DF14D724B8

P2888

Q34097983-E6EBF8B0-D1B8-4D37-8B7D-B5F769A8B732

P304

Q34097983-6559F676-FE3B-4AC0-9C4A-2F1A8314F901

P31

Q34097983-8ED17D1F-DB30-4F8E-8799-2FE0A987373F

P356

Q34097983-FD3178FD-1F13-47CD-AB78-B56738BB8E5A

P433

Q34097983-F10331F3-7C47-4A88-9782-EA61E2A4ED05

P478

Q34097983-68B9A3A7-7542-4C04-A1AB-5C3D40005CBF

P577

Q34097983-398680B8-F2ED-42EF-BF91-999972EC9B7C

P6179

Q34097983-1E08225E-E47C-434E-8FA5-C80F90E30C71

P698

Q34097983-9D51B525-8B77-410A-AC9B-BA3029D1CFBE

P356

S11033-010-9969-5

P1433

Molecular Biology Reports

P1476

Clinical significance of miR-2 ...... ¹ in hepatocellular carcinoma.

@en

P2093

Haoxiang Tan

http://www.w3.org/2001/XMLSchema#string

Jingsong Chen

http://www.w3.org/2001/XMLSchema#string

Jiong Bi

http://www.w3.org/2001/XMLSchema#string

Liangqi Cao

http://www.w3.org/2001/XMLSchema#string

Lianzhou Chen

http://www.w3.org/2001/XMLSchema#string

Longjuan Zhang

http://www.w3.org/2001/XMLSchema#string

Qian Wang

http://www.w3.org/2001/XMLSchema#string

Qiao Su

http://www.w3.org/2001/XMLSchema#string

Wen Li

http://www.w3.org/2001/XMLSchema#string

Xiaohui Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation

MicroRNA targets in Drosophila

Combinatorial microRNA target predictions

MicroRNA expression profiles classify human cancers

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

A brain-specific microRNA regulates dendritic spine development

miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.

Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated.

P2888

s11033-010-9969-5

P304

3029-3035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11033-010-9969-5

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037538786

http://www.w3.org/2001/XMLSchema#string

P698

20146005

http://www.w3.org/2001/XMLSchema#string